Background: Hip fracture has great impact on morbi-mortality, but a large percentage of patients do not receive treatment. Objectives: To know the characteristics of patients whith hip fracture and its evolution in the first 6 months. Methods: A prospective, 6-month follow-up study of patients over 60 years old admitted for hip fracture, evaluated in a local FLS. At 3 months after discharge, patients are evaluated for: epidemiological data, fracture income (days of admission, prior and discharge of osteoporosis (OP) drugs, general biochemistry and vitamin D), OP records and possible diseases or osteopenizing drugs, lumbar spine and hip Bone densitometry (BMD) lateral dorsal and lumbar spine radiology and the treatment was decided. The electronic history before and after 6 months of the fracture were reviewed. Results: Of 152 patients >60 years old, admitted in 2016 due hip fracture, 77 (51%) were during the first 6 months. However, radiology or BMD data were not available for 30 (39%) patients, 16 (21%) for death and 14 (18%) for loss of followup. Mean BMI was 26.02±6.2. The mean age of menopause was 49±5 years. 1% of the patients received corticosteroids and 2% of patients an osteopenizing disease (COPD) was found. Mean time of admission was 7.57±2.51 days. In 3% of the patients, before the fracture were receiving OP treatment, which continued to discharge. The mean level of calcium, phosphorus and alkaline phosphatase was normal. However, the mean level of 25OH vitamin D was 13.55±8.63 ng/ml (median: 12 ng/ml, range: <4 to 29 ng/ml). In 11 of the 27 (41%) patients, in whom radiology was available, the presence of vertebral fracture was demonstrated. The mean T-score for lumbar BMD was 1.8±1.65 DE (32%: the result was normal, 36% osteopenia, 32% OP), femoral neck 2.59±0.77 DE (27%: osteopenia, 77% OP) and in total hip: 2.56±0.86 DE (56%:osteopenia and 44% OPand In Ward of 3.2 DE. 100% of patients evaluated in Rheumatology, initiated treatment for OP: zoledronate: 40%, alendronate: 20%, denosumab: 25%, PTH: 15%. Conclusions: In patients with hip fracture: 1) Mortality is high (21%), in the first 6 months after fracture.
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Background: medical and social significance of osteoporosis is determined by its consequences -fractures of the vertebrae and the bones of the peripheral skeleton leading to high rates of mortality and disability among older adults. Purpose: to follow basic health and social consequences among the surviving patients with hip fractures aged 50 years or older at 6, 24 months. Objectives: The study included 432 patients (328 women and 104 men) with radiographic evidence of hip fractures that occurred with minimal trauma. Methods: Surgical treatment was performed in 171 (40,04%) patients, conservative treatment-261(59.96%). Results: tracked mortality in hip fractures in 432 patients. It was found that in the first 6 months in the surgical treatment of deaths registered in 11 (6,43%) patients and in 84 (32.18%) -the conservative (p<0.0001). After 12 months after fracture increased mortality rate after the surgical treatment and after conservative (12.9% and 44.81%, respectively, p<0.0001). It was revealed that in the first 6 months in patients with surgical treatments bedridden were 10 (8.0%) men and 78 -a group with conservative treatment (66.67%) (p<0.0001). Restriction of physical activity within the room was observed in 86 (68.8%) patients with surgery, and in 30 (25.64%) patients -with conservative treatment (p<0.0001). Aids used after surgical treatment of 105 (84.0%) patients after conservative -34 (29.0%) (p<0.0001). Social impact showed that after 6 months of observation revealed a low proportion of patients with complete recovery of function after a surgery, or after conservative treatment (8.0% and 5.13%, respectively; p=0.5). After 24 months from the time of the fracture using surgical methods bedridden stayed only 1 (0.4%) and 16 patients (13.68%) -with conservative methods (χ 2 =18,3; p<0.0001). There was a significant decrease in the number of patients with limited motion activity within the room in the group with surgery and in the group with conservative (10.4% and 26.5%, respectively, p=0.002 Background: Musculoskeletal disorders in RA are characterized by lesions of the peripheral joints, the development of local and systemic osteoporosis (OP), as well as a decrease in muscle mass and strength, which are currently being considered within the framework associated with chronic diseases syndrome sarcopenia and cachexia. Objectives: To determine the prevalence and the relationship between sarcopenia and OP in patients with RA. Methods: 156 RA patients were examined, of whom 83 postmenopausal women (mean age-61.7 years) and 73 males (mean age, 59 years). The control group consisted of 35 healthy subjects matched for age and sex. Exclusion criteria were: other rheumatic and endocrine diseases, severe somatic diseases, cancers, etc. The states of bone mineral density (BMD) at the lumbar spine (L1-L4) and femoral bone were assessed by dual-energy X-ray absorptiometry (DXA). Results: Most RA patients (83% women and 63% men) were observed to decrease in BMD of osteopenia/OP level. BMD were negatively correlated with radiographic stage of RA, the DAS 28 and HAQ. IPC also revealed significant correlations with laboratory parameters such as creatinine, total protein, albumin, rheumatoid factor, and 1,25 (OH) D. Investigation of body composition showed a statistically significant reduction ITM RA patients compared to the control group, with no differences between the groups for fat mass. Sarcopenia had 25% of women and 55% men with RA, whereas the control groups, 8.7% and 0%, respectively. The majority of patients of both sexes sarcopenia observed on the background of the normal range of body fat index. Status of TM in patients with RA was statistically significant (p<0,05) associated with femoral BMD and lumbar spine (r=0,3), BMI (r=0,5), force brush compression (r=0,4) RA radiographic stage (r= -0,4), indicators of total protein (r=0,5). Conclusions: Patients with RA, together with OP/osteopenia have a significant reduction in muscle (lean) mass. Sarcopenia in patients with RA was observed in the majority of men (55%) and 25% of women, significantly more than the control groups. Implementation of the DRA with the program "whole body" will allow time to identify not only bone, but also muscle loss in RA patients, which will help to intensify targeted therapy. Background: Celiac disease is a chronic autoimmune pathology that affects people with genetic predisposition, caused by a permanent intolerance to gluten. Its prevalence has been estimated at around 1% but about 30% of patients are diagnosed after age 60.Its diagnosis is made through clinical data, serological markers, study of duodenal biopsy (BD) and response to the gluten-free diet. The histological study (Marsh classification) remains the gold standard to the diagnosis and allows classification of the disease in 4 types: grade I (less histological lesion) to grade IV (total duodenal mucosal atrophy).In these patients the deficiency of 25-OH vitamin D (vit D) is very frequent and is one of the causes of osteomalacia associated with malabsorption. Objectives: To evaluate if there is a relation between the histological classification of Marsh and the bone metabolism in patients with a recent diagnosis of celiac disease. Methods: Prospective study, which included all patients with a recent diagnosis of celiac disease by the Digestive Service during the period 2014-2016. This diagnosis was made through a clinical, serological (anti-transglutaminase IgA, anti-endomysium IgA), histological BD and genetic study (HLA DQ2 and HLA DQ8) . All patients underwent a study of phospho-calcium metabolism including: calcemia, phosphataemia, vit D, PTH, alkaline phosphatases, 24-hour calciuria and a densitometric study (BMD). We present the inclusion data of these patients
